Clinical parameter | N | Early recurrence | Late recurrence | |||||
---|---|---|---|---|---|---|---|---|
Pvalue | HR (95% CI) | N (event) | Pvalue | HR (95% CI) | N (event) | |||
HER2 | pos. vs. neg. | 743 | 0.1378 | 1.36 (0.91 - 2.04) | 207 | 0.7788 | 1.10 (0.57 - 2.13) | 80 |
ER | pos. vs. neg. | 743 | 0.0048 | 0.63 (0.46 - 0.87) | 207 | 0.5023 | 1.19 (0.72 - 1.97) | 80 |
PR | pos. vs. neg. | 743 | 0.0004 | 0.61 (0.46 - 0.80) | 207 | 0.1027 | 1.45 (0.93 - 2.28) | 80 |
TNBC | TN vs. others | 743 | 0.0031 | 1.77 (1.21 - 2.59) | 207 | 0.0974 | 0.61 (0.34 - 1.10) | 80 |
Tumor size | ≥2 cm vs. <2 cm | 456 | 0.0008 | 1.91 (1.31 - 2.78) | 114 | 0.3184 | 1.29 (0.78 - 2.12) | 67 |
Grade | Grade 3 vs. others | 438 | 0.0038 | 1.87 (1.22 - 2.84) | 110 | 0.0692 | 0.60 (0.35 - 1.04) | 61 |
Age | ≥50 vs. <50 | 457 | 0.9933 | 1.00 (0.69 - 1.44) | 114 | 0.1144 | 0.67 (0.41 - 1.10) | 66 |